ViroPharma (VPHM) - A Tale of Two Drugs

ViroPharma markets two drugs: Vancocin for clostridium difficile infections, and Cinryze for rare hereditary angioedema. The company's investment potential is tied to how fast the latter can replace declining sales from the former. Read More...